Well Told Grants

Federal grant recipients / New Mexico

Federal grants to Exhalix, LLC

Albuquerque, New Mexico · Small businesses · UEI C1NVZ5M6E319

Exhalix, LLC in Albuquerque, New Mexico received $3.7 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was Biomedical Research and Research Training, with $2.3 million. In fiscal 2025 it was awarded $598,492.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Exhalix, LLC by fiscal year
Fiscal yearAwardsAmount
FY 20211$300,000
FY 20222$800,396
FY 20231$1.2 million
FY 20241$715,874
FY 20252$598,492

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Exhalix, LLC

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Biomedical Research and Research Training 93.8592$2.3 million
Cardiovascular Diseases Research 93.8371$500,000
National Center for Advancing Translational Sciences 93.3501$350,000
Aging Research 93.8661$300,396
Diabetes, Digestive, and Kidney Diseases Extramural Research 93.8471$248,492

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services6$3.7 million

Largest awards

The 6 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Heals?: an active hydrogen sulfide delivery technique for accelerated, effective wound healing - project summary/abstract the proposed effort addresses the need for novel therapeutic tools that improve chronic wound healing outcome. Recent studies show that patients with diabetic foot ulcers have a
ASST_NON_R44GM144027_075 on USAspending
Biomedical Research and Research TrainingAugust 22, 2023$2.0 million
Transdermal H2S sensing device for monitoring peripheral artery disease - project summary/abstract peripheral artery disease (PAD) and small vessel disease (SVD) are the consequences of damage to the endothelial cells that line all vessels, leading to inadequate skin perfusion, end-organ failure, an
ASST_NON_SB1HL121871_075 on USAspending
Cardiovascular Diseases ResearchAugust 15, 2022$500,000
Genie: s: on-demand sulfide synthesis and delivery platform technology for ischemia therapy - project summary/abstract peripheral artery disease (PAD) is a vascular insufficiency problem that affects more than 20 million or nearly 7% of the U.S. Population. Nearly 1 in 10 pad patients eventually deve
ASST_NON_R43TR005284_075 on USAspending
National Center for Advancing Translational SciencesSeptember 15, 2025$350,000
Repair by local infusion of sulfides (relis?) for treatment of disadvantaged surgical incisions - project summary/abstract the proposed effort addresses the need for a novel therapeutic tool that improves the recovery of at-risk surgical incisions. There are 48.3 million surgical procedures performe
ASST_NON_R43AG076027_075 on USAspending
Aging ResearchAugust 10, 2022$300,396
Heals?: an active hydrogen sulfide delivery technique for accelerated, effective wound healing - project summary/abstract the proposed effort addresses the need for novel therapeutic tools that improve chronic wound healing outcome. Recent studies show that patients with diabetic foot ulcers have a
ASST_NON_R43GM144027_075 on USAspending
Biomedical Research and Research TrainingSeptember 17, 2021$300,000
A hydrogen sulfide delivery technology for organ preservation therapy - project summary/abstract nearly 1 in 3 people with diabetes and 1 in 5 people with high blood pressure suffer from chronic kidney disease (CKD), while approximately 2 in 1,000 americans are living with end-stage kidney disease (
ASST_NON_R43DK143762_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchSeptember 8, 2025$248,492

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Exhalix, LLC get?

$3.7 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Exhalix, LLC the most?

The Department of Health and Human Services, with $3.7 million in 6 awards.

What is Exhalix, LLC's largest federal grant?

$2.0 million under Biomedical Research and Research Training, with its first action in the period on August 22, 2023. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Exhalix, LLC?

Its largest are Biomedical Research and Research Training, Cardiovascular Diseases Research and National Center for Advancing Translational Sciences.

Other grant recipients in Albuquerque

Largest federal grant recipients in New Mexico · Federal grants in New Mexico